Thought Leadership
LifeSci Talks COA Series | From Interview to Endpoint: Understanding the Importance of Patient Listening to Build Better Outcomes
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with John Reites, Co-Founder and CEO of THREAD research to discuss the importance of patient listening to build better clinical trial endpoints. They delve...
eCOA Vendor Localization Best Practices Checklist
One of the main challenges for pharma/biotech companies regarding clinical trials is prolonged eCOA study start-up. It is paramount to choose the right eCOA platform for each study. Sponsors must consider the study’s specific needs, such as user-friendliness, compliance, and...
Selecting an eCOA Vendor to Best Fit Localization Needs
Discover how it is paramount to choose the right eCOA platform for each study. Learn the best-in-class eCOA platform localization capabilities surrounding the four core pillars of content management, internationalization, post-localization testing, and content reuse. Trust...
LifeSci Talks COA Series | Exploring the Value Add of In-Study Interviews as a Critical COA Endpoint
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Tom Willgoss, Patient-Centered Outcomes Research Chapter Lead, UK Site Head for Data Sciences at Roche to discuss the value of understanding and measuring...
AI and MT "Ask an Expert" Office Hours - 4/10/2024
TransPerfect's experts gather to answer questions from global pharma, biotech, and medical device leaders regarding AI and MT use cases, challenges, opportunities, best practices, and more....
LifeSci Talks COA Series | Breaking the Hype Cycle: An Objective Look at Remote Research Strategies in DCTs
In the first part of TransPerfect's latest LifeSci Talks episode, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, with guest Dr. Michelle Longmire, CEO of Medable, spoke about how a Stanford doctor transitioned into a career of entrepreneurship, creating a...
LifeSci Talks COA Series | Exploring the Intersection of Clinical Practice and Entrepreneurship: Technological Innovation in Clinical Research
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr Michelle Longmire, CEO of Medable, to discuss her journey from clinical practice to entrepreneurship, driven by a passion for rare disease, and the...
Clinical Outcomes Assessments (COAs) in Clinical Trials: Copyright and Licensing
Navigating the intricate details of licensing and copyright agreements in COAs is a complex task, presenting possible challenges to multi-licensor coordination or in managing evolving study protocols. This complexity, however, is a necessity, serving as an essential tool to...
Localizing Platforms for Digital Health: The Importance of Post-Localization Context Review
In a landscape defined by continuous technological advancement, many organizations in the life sciences industry strive to increase audience engagement through digital modalities, such as mobile and web applications or web portals. Building a robust technological...
PRO Scheduling Considerations: Assessing Patient & Caregiver Burden in Clinical Trials
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Andrew Lloyd, Director at Acaster-Lloyd Consulting, to spotlight the burden of clinical research for patients, and their caregiver/family dynamics. From...
LifeSci Talks COA Series | Licensing Challenges vs. eCOA Vendor Capabilities
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA & Digital Implementation, to cover the intricacies of clinical trial licensing, contract variations among eCOA providers,...
COA White Paper | The Tale of Two Trials
In “The Tale of Two Trials,” Mark Wade takes an in-depth look at the benefits and drawbacks of the traditional, paper-based outcomes assessment method, as well as the advantages of the emerging electronic clinical outcomes assessment (eCOA) solutions. With each having the...
Data Standardization COA Whitepaper
With the surge of eCOA providers deploying differing technology platforms with differing architecture and file exchange processes, the landscape is shifting and becoming opaque. Deploying an eCOA solution faster and more costeffectively is a clearer focus for Sponsors now. Indeed...
LifeSci Talks COA Series | Decoding Decentralized Trials: Navigating Novel Decentralized Research Challenges and Complexity
DCTs have picked up significantly in previous years, catalyzed by the pandemic and a move to remote research. With this move comes a host of new challenges, including those surrounding technical interoperability, resistance to adopting new technologies, and the need for...
LifeSci Talks COA Series | AI-Powered Innovations in Clinical Trials: Optimizing Every Step
Explore how artificial intelligence is rapidly changing the landscape of clinical trials, from discovering new therapies and complex calculations to protocol optimization. Discover how AI can generate study protocols, consent forms, and more, saving time and resources. Join us to...
The Role of Artificial Intelligence (AI) in Clinical Outcome Assessments (COAs)
Artificial Intelligence (AI) is the new frontier for content creation, reuse of language assets; saving time and effort in the curation of documentation. The widely adopted generative AI tools, such as ChatGPT have altered the landscape, in many instances transforming authors...
LifeSci Talks COA Series | The Age of Bring Your Own Device: Considerations for Accessibility in Trial Design
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr. Florence Mowlem, VP of Science at ObvioHealth, to discuss maximizing patient accessibility in trial design. This includes implementing accommodations for patients...
Harnessing the Power of Electronic Clinical Outcomes Assessments (eCOA) Technology
Digital technologies are reshaping rare disease studies, placing the question of data integrity firmly in the spotlight. In this recap from our C3 Summit Session titled Harnessing the Power of Electronic Clinical Outcomes Assessments (eCOA) Technology, we examine the impact of...
LifeSci Talks COA Series | Data Science: The New Frontier
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Dr. Elizabeth Bacci, Senior Research Scientist at Evidera, to discuss critical aspects of developing meaningful and relevant Digital Health instruments. The...
LifeSci Talks COA Series | The Future of Capturing Patient Data in Clinical Trials: DCTs, Site Staff Burden, and Regulation Considerations with Paul O'Donohoe
Mark Wade interviews Paul O'Donohoe, Senior Director of Product for eCOA and COA at Medidata. They delve into the challenges and opportunities of adopting decentralized clinical trials (DCTs) and explore topics such as mixed modalities for data capture, patient burden, site...
Digitizing Multilingual COAs: A Practical Guide
Download our guide to ensuring seamless digitization of your multilingual COAs. ...
The Role of Qualitative Interviews in Ensuring a Patient-Centered Approach to Clinical Trials
Discover how qualitative interviews (CE, CD, PE, EI) enhance clinical trials. Learn best practices for conducting patient-centered interviews and ensuring accurate, meaningful data. Trust TransPerfect Life Sciences for expert interviewers and top-quality translation and...
